News Medical on MSN1d
AI model identifies potential risk genes for Parkinson's disease
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
biopharma-reporter1h
Setback for Inhibikase Parkinson’s therapy
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
Medical News Today1d
Taking longer to get to REM sleep could indicate Alzheimer's disease
A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...
Medscape1d
Alzheimer’s Disease: The Cholinergic Revival
A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...
Armed robbery in Revesby1d
AI Model Flags Risk Genes for Parkinson's Disease
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Joplin Globe5d
Feinstein Institutes Reveals Brain Changes Seen Years Before Parkinson’s Symptoms in Sleep Disorder Patients
New research from The Feinstein Institutes for Medical Research reveals that brain imaging can detect subtle abnormalities in ...
Neurology Advisor2d
Oral SIGMAR1 Targeting Agent Looks Promising in Early Alzheimer Disease Trial
Topline data were published from a phase 2b/3 study evaluating blarcamesine for the treatment of early Alzheimer disease.
Medscape13d
Processed Red Meat Tied to Increased Dementia Risk
Consuming just two servings of processed red meat per week is associated with a 13% increased risk for dementia, a large, ...